Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;111(2):416-420.
doi: 10.1016/j.athoracsur.2020.05.101. Epub 2020 Jul 16.

Validation of Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules

Affiliations

Validation of Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules

Maren E Shipe et al. Ann Thorac Surg. 2021 Feb.

Abstract

Background: Granulomas caused by infectious lung diseases can present as indeterminate pulmonary nodules (IPN). This study aims to validate an enzyme immunoassay (EIA) for Histoplasma immunoglobulin G (IgG) and immunoglobulin M (IgM) for diagnosing benign IPN in areas with endemic histoplasmosis.

Methods: Prospectively collected serum samples from patients at Vanderbilt University Medical Center (VUMC [n = 204]), University of Pittsburgh Medical Center (n = 71), and University of Cincinnati (n = 51) with IPN measuring 6 to 30 mm were analyzed for Histoplasma IgG and IgM with EIA. Diagnostic test characteristics were compared with results from the VUMC pilot cohort (n = 127). A multivariable logistic regression model was developed to predict granuloma in IPN.

Results: Cancer prevalence varied by cohort: VUMC pilot 60%, VUMC validation 65%, University of Pittsburgh Medical Center 35%, and University of Cincinnati 75%. Across all cohorts, 19% of patients had positive IgG titers, 5% had positive IgM, and 3% had positive both IgG and IgM. Of patients with benign disease, 33% were positive for at least one antibody. All patients positive for both IgG and IgM antibodies at acute infection levels had benign disease (n = 13), with a positive predictive value of 100%. The prediction model for granuloma in IPN demonstrated an area under the receiver-operating characteristics curve of 0.84 and Brier score of 0.10.

Conclusions: This study confirmed that Histoplasma EIA testing can be useful for diagnosing benign IPN in areas with endemic histoplasmosis in a population at high risk for lung cancer. Integrating Histoplasma EIA testing into the current diagnostic algorithm where histoplasmosis is endemic could improve management of IPN and potentially decrease unnecessary invasive biopsies.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Area under the receiver operating curve (AUC) for fungal granuloma prediction model which included IgG and IgM compared to the simplified model. The simplified model contained the clinical variables only.

Similar articles

Cited by

References

    1. Gould MK, Tang T, Lee J, et al. Recent Trends in the Identification of Incidental Pulmonary Nodules. Am J Respir Crit Care Med. 2015;192(10):1208–1214. doi:10.1164/rccm.201505-0990oc - DOI - PubMed
    1. Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: When is it lung cancer? Diagnosis and management of lung cancer? Chest. 2013;143(5 SUPPL):93–120. doi:10.1378/chest.12-2351 - DOI - PMC - PubMed
    1. MANOS NE,FEREBEE SH, KERSCHBAUM WF Geographic variation in the prevalence of histoplasmin sensitivity. Dis Chest. 1956;29(6):649–668. doi:10.1378/chest.29.6.649 - DOI - PubMed
    1. Starnes SL, Reed MF, Meyer CA, et al. Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis? J Thorac Cardiovasc Surg. 2011;141(3):688–693. doi:10.1016/j.jtcvs.2010.08.045 - DOI - PubMed
    1. Grogan EL, Deppen SA, Ballman KV., et al. Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage i non-small cell lung cancer. Ann Thorac Surg. 2014;97(4):1142–1148. doi:10.1016/j.athoracsur.2013.12.043 - DOI - PMC - PubMed

Publication types

Substances